透過您的圖書館登入
IP:18.222.37.169
  • 期刊

Pulmonary Embolism after Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Report of a Case

經導管動脈化學栓塞術後併發肺栓塞:一病例報告

摘要


對於肝細胞癌患者施行經導管動脈化學栓塞術後,已有併發肺栓塞的病例報告。我們報告一例肝細胞癌患者在施行經導管動脈化學栓塞術後,在臨床上表現出心肺窘迫的症狀。經由理學檢查、實驗室數據及影像學檢查,強烈懷疑為併發肺栓塞。再經由核子醫學掃描及肺動脈血管攝影,確定為上述診斷。病患在施予經靜脈肝素灌注及其它必要之支持性治療後,完全康複無後遺症。臨床醫師必須瞭解到肺栓塞乃是經管動脈化學栓塞術後的一種嚴重併發症,及早診斷及治療甚為重要。

並列摘要


Pulmonary embolism is an important cause of morbidity and mortality. Some patients develop pulmonary embolism after transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma, because the Lipiodol oil embolizes to the pulmonary arterial circulation. We reported one patient with hepatocellular carcinoma complicated by cardio-pulmonary distress secondary to TA CE. The clinical history, laboratory data and image study all supported the diagnosis of pulmonary embolism. Definite diagnosis was confirmed by scintigraphy and pulmonary angiography. This patient fully recovered from the respiratory event after installation of heparin and other supportive care. The clinician must be aware of this potentially fatal complication of TACE. Prompt diagnosis is necessary for optimal management.

延伸閱讀